← Browse by Condition
Medical Condition
tumor microenvironment
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
ClinicalMetric tracks all active clinical trials for tumor microenvironment sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 2 1
Top Sponsors
1 trial
1 trial
1 trial
NCT06687876 Phase 2
Recruiting
Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy
Enrollment
14 pts
Location
Netherlands
Sponsor
Amsterdam UMC, location VUmc
NCT07375420
Recruiting
Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
Enrollment
50 pts
Location
United Kingdom
Sponsor
University of Surrey
NCT06182657
Recruiting
The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
Enrollment
300 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology